|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/53 | |||
| A61K 45/06 | |||
| A61K 31/195 | |||
| A61K 31/506 | |||
| A61K 31/5377 | |||
| A61P 15/00 |
| (11) | Patento numeris | 2387404 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10700938.3 |
| Europos patento paraiškos padavimo data | 2010-01-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-11-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-06-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/000029 |
| Data | 2010-01-07 |
| (87) | Numeris | WO 2010/081647 |
| Data | 2010-07-22 |
| (30) | Numeris | Data | Šalis |
| 09000619 | 2009-01-17 | EP | |
| 09002177 | 2009-02-17 | EP |
| (72) |
SANDNER, Peter, DE
STASCH, Johannes-Peter, DE
BÖTTCHER, Michael-Friedrich, DE
|
| (73) |
Bayer Intellectual Property GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (54) | Sgc stimulators and activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| Sgc stimulators and activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |